Trippler, Lydia
Ali, Said Mohammed
Masoud, Msanif Othman
Mohammed, Zahor Hamad
Amour, Amour Khamis
Suleiman, Khamis Rashid
Ame, Shaali Makame
Kabole, Fatma
Hattendorf, Jan
Knopp, Stefanie
Clinical trials referenced in this document:
Documents that mention this clinical trial
One-year impact of behavioural interventions on schistosomiasis-related knowledge, attitude and practices of primary schoolchildren in Pemba, Tanzania
https://doi.org/10.1186/s40249-024-01251-y
Impact of chemical snail control on intermediate host snail populations for urogenital schistosomiasis elimination in Pemba, Tanzania: findings of a 3-year intervention study
https://doi.org/10.1186/s13071-024-06565-2
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PR00P3_179753 / 1)
Article History
Received: 11 July 2024
Accepted: 1 November 2024
First Online: 26 November 2024
Declarations
:
: The SchistoBreak study protocol was waived by the ethics committee in Switzerland (Ethikkommission Nordwest- und Zentralschweiz; EKNZ) on 23 October 2019 (Req-2019-00951). It subsequently received annual ethical approval by the Zanzibar Health Research Institute (ZAHRI). The first approval was given on 13 December 2019 (ZAHREC/03/PR/December/2019/12), and the latest approval was given on 31 March 2023 (ZAHREC/04/AMEND/MARCH/2023/03). The study was registered prospectively at ISRCTN (ISCRCTN91431493). At the beginning of each annual intervention period, the leaders of the IUs (shehas) were invited to meetings at the PHL-IdC. In the meetings, updates on the SchistoBreak study results were presented. Moreover, challenges of surveys and interventions were discussed and concerns addressed, and the shehas were invited to support the project by announcing the forthcoming activities in their communities.
: Not applicable.
: The authors declare no competing interests.